Home › Core › ISCC-IDs › 28C68Drwdtcrb

View ISCC-ID

Core Data

28C68Drwdtcrb
ISCC-ID - digital asset identifier
CCNmvcjNzYhcs-CTURpMbEfPfTc-CDaycfoDN8vUg-CRH8Ai446NGEj
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

potential value of triple drug therapy with ivermectin diethylcarbamazine and albendazole ida to accelerate elimination of lymph

Ledger Reference

coblo
Source Ledger/Blockchain
12404360
N-th ISCC Decleration on source ledger
23867462390a747ddd237b56f1e4e34202b64c9f43e19f0a3ab5bb57984625de
Hash of block that includes the ISCC-DECLARATION
0dac0541b680d800a0db448c25c770e162ecf00df4d60f3a71660f7a23c7b2bc
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Peter U. Fischer", "@type": "Person"}, {"name": "Christopher L. King", "@type": "Person"}, {"name": "Julie A. Jacobson", "@type": "Person"}, {"name": "Gary J. Weil", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://digitalcommons.wustl.edu/cgi/viewcontent.cgi?article=6625&context=open_access_pubs", "encodingFormat": "application/pdf"}], "publisher": {"name": "Public Library of Science (PLoS)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1371/journal.pntd.0005163", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCNmvcjNzYhcs-CTURpMbEfPfTc-CDaycfoDN8vUg-CRH8Ai446NGEj", "propertyID": "ISCC"}], "datePublished": "2017-01-05"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close